title: Retinal vein thrombosis: The Internist's role in the etiologic and therapeutic management.
abstract: Retinal vein occlusion is a common and important cause of vision loss. In general, knowledge about this condition is scant within an internist's practice but the condition is relevant because of its association with other chronic ailments. A diagnosis of RVO should prompt the investigation of conditions needing chronic management in these patients. In this review we summarize the clinical presentation of RVO, its classification, associated risk factors, and treatment focused in the internist's scope of practice.
authors.affiliation: Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Garcia-Horton
authors.affiliation: Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada.
authors.forename: Fatimah
authors.initials: F
authors.lastname: Al-Ani
authors.affiliation: Department of Medicine, Division of Hematology, University of Western Ontario, London, ON, Canada; Department of Epidemiology and Biostatistics, University of Western Ontario, London, ON, Canada. Electronic address: alejandro.lazolangner@lhsc.on.ca.
authors.forename: Alejandro
authors.initials: A
authors.lastname: Lazo-Langner
mesh_terms: D000925:Anticoagulants / Q000627:therapeutic use; D006495:Heparin, Low-Molecular-Weight / Q000627:therapeutic use; D006801:Humans; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D011379:Prognosis; D012169:Retinal Vein / Q000187:drug effects / Q000473:pathology*; D012170:Retinal Vein Occlusion / Q000175:diagnosis* / Q000188:drug therapy* / Q000453:epidemiology / Q000473:pathology; D014859:Warfarin / Q000627:therapeutic use
chemical_list: D000925:Anticoagulants; D006495:Heparin, Low-Molecular-Weight; D010975:Platelet Aggregation Inhibitors; D014859:Warfarin
keywords: Anticoagulation; Pathophysiology; Retinal vein occlusion; Treatment